Cargando…

P1067: PHASE 2 STUDY OF ORAL THALIDOMIDE-CYCLOPHOSPHAMIDE-DEXAMETHASONE FOR RECURRENT/REFRACTORY ADULT LANGERHANS CELL HISTIOCYTOSIS

Detalles Bibliográficos
Autores principales:	Wang, J.-N., Liu, T., Zhao, A.-L., Pan, B.-J., Sun, J., Li, J., Zhou, D.-B., Duan, M.-H., Cao, X.-X.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430653/ http://dx.doi.org/10.1097/01.HS9.0000847136.19477.8e

Ejemplares similares

PB2011: CHIDAMIDE COMBINED WITH THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE (TC2D) AS AN ORAL QUADRUPLET REGIMEN FOR RELAPSED/REFRACTORY MYELOMA PATIENTS: INITIAL RESULTS OF A PHASE IIA, MULTICENTER TRIAL
por: Li, Y., et al.
Publicado: (2022)

P11: IXAZOMIB WITH CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN RELAPSED OR REFRACTORY MYELOMA: MUKEIGHT PHASE II RANDOMISED CONTROLLED TRIAL RESULTS
por: Auner, H, et al.
Publicado: (2022)

P1133: CHIDAMIDE PLUS PREDNISONE, CYCLOPHOSPHAMIDE, AND THALIDOMIDE (CPCT) FOR RELAPSED OR REFRACTORY PERIPHERAL T-CELL LYMPHOMA: A MULTICENTER PHASE II TRIAL
por: Liang, Jinhua, et al.
Publicado: (2023)

P1097: MEK-INHIBITORS IN TREATMENT OF LANGERHANS CELL HISTIOCYTOSIS
por: Burtsev, E., et al.
Publicado: (2022)

Purely cutaneous Langerhans cell histiocytosis presenting as an ulcer on the chin in an elderly man successfully treated with thalidomide
por: Subramaniyan, Radhakrishnan, et al.
Publicado: (2015)

Cholesteatoma Masquerading as Recurrent Langerhans Cell Histiocytosis
por: Gendre, Adrien, et al.
Publicado: (2023)

Multisystem Langerhans cell histiocytosis presenting as an oral lesion
por: George, Kallarakkal Thomas, et al.
Publicado: (2013)

Clofarabine monotherapy in two patients with refractory Langerhans cell histiocytosis
por: Irie, Masahiro, et al.
Publicado: (2021)

Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation
por: Crusoe, Edvan De Queiroz, et al.
Publicado: (2020)

P1122: EFFICACY OF ALPELISIB IN PI3K-DRIVEN LANGERHANS CELL HISTIOCYTOSIS
por: Mazor, R., et al.
Publicado: (2022)

Langerhans cell histiocytosis
por: Aruna, D. R., et al.
Publicado: (2011)

Langerhans cell histiocytosis
por: Kumar, Manish, et al.
Publicado: (2018)

Necrobiotic xanthogranuloma associated with smoldering multiple myeloma: satisfactory response to cyclophosphamide, dexamethasone, and thalidomide
por: de Mello, Renan Bernardes, et al.
Publicado: (2019)

Renal pathological changes after successful treatment of LCDD using cyclophosphamide, thalidomide, and dexamethasone
por: Wang, Di, et al.
Publicado: (2021)

Langerhans cell histiocytosis of the perianal region.
por: Foster, A., et al.
Publicado: (2003)

Initial presentation of Pulmonary Langerhans cell histiocytosis as recurrent spontaneous pneumothoraces
por: Keane, Ruaidhri J., et al.
Publicado: (2020)

P1067: ESTIMATING THE RELATIVE EFFICACY OF FAVEZELIMAB WHEN USED IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH PD-1–REFRACTORY CLASSICAL HODGKIN LYMPHOMA
por: Armand, Philippe, et al.
Publicado: (2023)

PB1808: LANGERHANS CELL HISTIOCYTOSIS IN ADOLESCENT PATIENTS: A SINGLE-CENTER RETROSPECTIVE STUDY
por: Cai, H., et al.
Publicado: (2022)

PB2324: USE OF COMBINATION OF THALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN PATIENTS WITH REFRACTORY/RELAPSED NON-HODGKIN LYMPHOMA: A PALLIATIVE CHEMOTHERAPY STRATEGY.
por: Martinez, Celia, et al.
Publicado: (2023)

Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study
por: Hjorth, Martin, et al.
Publicado: (2012)

Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma
por: Iida, Shinsuke, et al.
Publicado: (2018)

Cytogenetic abnormalities in Langerhans cell histiocytosis.
por: Betts, D. R., et al.
Publicado: (1998)

Multisystem Langerhans cell histiocytosis with diabetes insipidus in an adult
por: Liu, Kh, et al.
Publicado: (2022)

Disseminated Cytomegalovirus Infection in a Child with Langerhans Cell Histiocytosis
por: Iswarya, Polina Siri, et al.
Publicado: (2022)

Langerhans cell histiocytosis of the sternum
por: Tsuchie, Hiroyuki, et al.
Publicado: (2009)

Pulmonary langerhans cell histiocytosis
por: Suri, Harpreet S, et al.
Publicado: (2012)

Langerhans cell histiocytosis of the sacrum
por: Hatem, M.A.
Publicado: (2015)

Langerhans cell histiocytosis of the bone
por: Huang, Wen-Chih, et al.
Publicado: (2017)

Langerhans Cell Histiocytosis of the Tonsil
por: Cipolla, Federica, et al.
Publicado: (2022)

Langerhans Cell Histiocytosis of the Mandible
por: Padmanaban, Kamalakannan, et al.
Publicado: (2022)

P21 EFFECTIVENESS AND SAFETY OF DELAYED BORTEZOMIB, THALIDOMIDE AND DEXAMETHASONE (VTD) REGIMEN
por: Del Fabro, V., et al.
Publicado: (2023)

P544: SINGLE-SYSTEM UNIFOCAL ADULT LANGERHANS CELL HISTIOCYTOSIS: A SINGLE-CENTER RETROSPECTIVE STUDY
por: Lang, Min, et al.
Publicado: (2023)

Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study
por: Donadieu, Jean, et al.
Publicado: (2019)

Cladribine and cytarabine in children refractory high risk multisystem Langerhans cell histiocytosis
por: Wang, Wenqian, et al.
Publicado: (2023)

Striatal Involvement in Neurodegenerative Langerhans Cell Histiocytosis
por: de Haan, Sven, et al.
Publicado: (2019)

P1043: EFFICACY AND SAFETY OF TRAMETINIB IN ADULTS WITH LANGERHANS CELL HISTIOCYTOSIS AND ERDHEIM-CHESTER DISEASE
por: Latyshev, Vitalii, et al.
Publicado: (2023)

P1039: LOW DOSE CYTARABINE FOR ADULT PATIENTS WITH NEWLY DIAGNOSED LANGERHANS CELL HISTIOCYTOSIS: A SINGLE ARM, SINGLE CENTER, PROSPECTIVE PHASE 2 STUDY
por: Chang, Long, et al.
Publicado: (2023)

The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma
por: Hashimoto, Shigeo, et al.
Publicado: (2016)

Langerhans Cell Histiocytosis: A Diagnostic Challenge in the Oral Cavity
por: Altay, Mehmet Ali, et al.
Publicado: (2017)

Oral manifestation of Langerhans cell histiocytosis: a case report
por: Luz, Julia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v86h1tagk0dj7ksnouavkbg2am